Incentives for Global Health
313 Saint Ronan Street
New Haven, CT 06511
The Health Impact Fund would attract products likely to achieve great impact against diseases of poverty. Innovators would promote these products in an unconventional way. Rather than seek large sales at high markups, they would aim for a collaborative public-health strategy that reduces the overall disease burden as cost-effectively as possible. If a product could make its target disease fade away, it would earn large rewards even with shrinking sales.
Governments have reason to support the Health Impact Fund because it would massively contribute to fulfilling the SDGs and would also make pharmaceutical innovators far better prepared to tackle new infectious diseases like COVID-19.
Too high prices for patented medications
Misalignment of innovator rewards and health outcomes